Zilart 125 mg tablete za oralnu suspenziju
Name | Zilart 125 mg tablete za oralnu suspenziju |
---|---|
Marketing Authorisation Number | HR-H-474588710 |
Active Substance | deferasiroks |
Composition | svaka tableta za oralnu suspenziju sadrži 125 mg deferasiroksa |
Pharmaceutical Form | tableta za oralnu suspenziju |
Packaging [MA Number for Packaging] | 28 tableta u blisteru, u kutiji [HR-H-474588710-01] 84 tablete u blisteru, u kutiji [HR-H-474588710-02] 252 tablete u blisteru, u kutiji [HR-H-474588710-03] |
Manufacturer | Pharmascience International Limited, Nicosia, Cipar |
Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
Marketing Authorisation Date | 31.05.2023 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/22-02/122 |
Registration Number | 381-12-01/154-23-11 |
Prescription | na recept |
Type of prescription | ograničeni recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | V03AC03 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | preuzmi |
Educational materials for healthcare professionals |
Brošura za zdravstvene radnike, verzija 1 |
Educational materials for patients / caregivers |
Brošura za bolesnike, verzija 1 |